Literature DB >> 12213139

Preventive health care measures before and after start of renal replacement therapy.

Wolfgang C Winkelmayer1, William Owen, Robert J Glynn, Raisa Levin, Jerry Avorn.   

Abstract

OBJECTIVE: To describe utilization of preventive health care measures in patients with chronic kidney disease (CKD), both in the year prior to onset of renal replacement therapy (RRT), and in the first year of RRT.
METHODS: We identified a large cohort of patients with CKD in the New Jersey Medicaid and Medicare programs with fixed enrollment into the cohort at 1 year prior to RRT. We applied commonly used quality assurance instruments (Health Plan Employer Data and Information Set measures) and defined levels and correlates of use of preventive care measures before and after RRT. These included mammography, Pap smear testing, prostate cancer screening, diabetic eye exams, and glycosylated hemoglobin testing (HbA1c). We employed logistic regression models with adjustment for age, race, gender, comorbidity, timing of first nephrologist contact, socioeconomic status, and calendar year of first RRT.
RESULTS: Overall, screening rates were low with the exception of diabetic eye exams. Prostate cancer screening, diabetic eye exams, and HbA1c testing were performed less often after onset of RRT compared to the year before (P < .05). Although screening rates before RRT improved considerably over the period of observation for these measures (P < .05), this was not the case once patients were on RRT.
CONCLUSIONS: Preventive health care interventions remain underutilized among RRT patients. Greater attention to such preventive measures could lead to significant improvements in the health status of such vulnerable patients. Thus, quality improvement of the general health care for patients on RRT should become a priority in renal health policy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213139      PMCID: PMC1495089          DOI: 10.1046/j.1525-1497.2002.11021.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  18 in total

1.  Applying managed care performance measures in community pharmacy-based outcomes research.

Authors:  K M Capó; D R Rutledge
Journal:  J Am Pharm Assoc (Wash)       Date:  1999 May-Jun

2.  Applying HEDIS clinical measures to community health centers: a feasibility study.

Authors:  A Zuvekas; R Hur; D Richmond; D Stevens; C Ayoama; C Modica
Journal:  J Ambul Care Manage       Date:  1999-10

3.  Late referral and modality choice in end-stage renal disease.

Authors:  W C Winkelmayer; R J Glynn; R Levin; W Owen; J Avorn
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

4.  Eye examinations for VA patients with diabetes: standardizing performance measures.

Authors:  D Jones; A Hendricks; C Comstock; A Rosen; B H Chang; J Rothendler; C Hankin; M Prashker
Journal:  Int J Qual Health Care       Date:  2000-04       Impact factor: 2.038

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?

Authors:  B Djavan; S Shariat; K Ghawidel; K Güven-Marberger; M Remzi; J Kovarik; W H Hoerl; M Marberger
Journal:  Urology       Date:  1999-06       Impact factor: 2.649

7.  Development of a comorbidity index using physician claims data.

Authors:  C N Klabunde; A L Potosky; J M Legler; J L Warren
Journal:  J Clin Epidemiol       Date:  2000-12       Impact factor: 6.437

8.  Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Authors:  P Maisonneuve; L Agodoa; R Gellert; J H Stewart; G Buccianti; A B Lowenfels; R A Wolfe; E Jones; A P Disney; D Briggs; M McCredie; P Boyle
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

9.  Quality of care in investor-owned vs not-for-profit HMOs.

Authors:  D U Himmelstein; S Woolhandler; I Hellander; S M Wolfe
Journal:  JAMA       Date:  1999-07-14       Impact factor: 56.272

10.  Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients.

Authors:  H Inamoto; R Ozaki; T Matsuzaki; M Wakui; T Saruta; A Osawa
Journal:  Nephron       Date:  1991       Impact factor: 2.847

View more
  7 in total

1.  The care of patients with chronic kidney disease.

Authors:  Annamaria T Kausz; Andrew S Levey
Journal:  J Gen Intern Med       Date:  2002-08       Impact factor: 5.128

2.  Association of Primary Care Involvement with Death or Hospitalizations for Patients Starting Dialysis.

Authors:  Samuel A Silver; Sarah E Bota; Eric McArthur; Kristin K Clemens; Ziv Harel; Kyla L Naylor; Manish M Sood; Amit X Garg; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-05       Impact factor: 8.237

3.  Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?

Authors:  Lisbeth Selby; Andrew Hoellein; John F Wilson
Journal:  Dig Dis Sci       Date:  2010-07-29       Impact factor: 3.199

4.  Comparison of stage at diagnosis of cancer in patients who are on dialysis versus the general population.

Authors:  Shilpa Taneja; Sreedhar Mandayam; Zainab Z Kayani; Yong-Fang Kuo; Vahakn B Shahinian
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-16       Impact factor: 8.237

5.  Annual wellness visits and care management before and after dialysis initiation.

Authors:  Virginia Wang; Lindsay Zepel; Clarissa J Diamantidis; Valerie A Smith; Sarah Hudson Scholle; Matthew L Maciejewski
Journal:  BMC Nephrol       Date:  2021-05-05       Impact factor: 2.388

Review 6.  Minding the gap and overlap: a literature review of fragmentation of primary care for chronic dialysis patients.

Authors:  Virginia Wang; Clarissa J Diamantidis; JaNell Wylie; Raquel C Greer
Journal:  BMC Nephrol       Date:  2017-08-29       Impact factor: 2.388

7.  High rates of cancer screening among dialysis patients seen in primary care a cohort study.

Authors:  Bjorg Thorsteinsdottir; LaTonya J Hickson; Priya Ramar; Megan Reinalda; Nicholas W Krueger; Cynthia S Crowson; Andrew D Rule; Paul Y Takahashi; Rajeev Chaudhry; Sidna M Tulledge-Scheitel; Jon C Tilburt; Amy W Williams; Robert C Albright; Sarah K Meier; Nilay D Shah
Journal:  Prev Med Rep       Date:  2018-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.